SLXN Amends Memorandum to Boost Authorized Shares to 59M, Expand 2024 Plan Evergreen to 10% Fully Diluted, Approve 1-for-10 Reverse Split
Silexion Therapeutics Corp Ordinary Shares · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $4.98
-17% in 7d after detection
Post-detection moves
1h
—
1d
-5.1%
3d
-13%
7d
-17%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS